Clinical Trial

RSV Burden in Outpatient and Hospital Settings

Study acronym: Oursyn
Recruiting
View on ClinicalTrials.gov →
Summary
Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-02-04; most recent amendment 2026-03-17.
Status change: Not Yet Recruiting → Recruiting 2021-03-18
Trial Details
NCT Number NCT04743609
Lead Sponsor Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: Sanofi
Conditions RSV Infection, Children, Only, Outpatient, Otitis
Enrollment 1,900 participants
Start Date 2021-02-08
Primary Completion 2026-12-08 (estimated)
Study Completion 2026-12-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-19